Arch Venture raises $1.4bn fund to spur ‘healthcare revolution’
Arch Venture announces that it raised the sum across two funds, with the capital earmarked for early stage biotechs.
Archives for April 2, 2020
US FDA closes inspection of Biocon’s insulin facility
The company announces that the problems raised by the FDA in February have been cleared.